ClinicalTrials.Veeva

Menu

The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease

T

Turkish Ophthalmology Society

Status

Completed

Conditions

Behçet's Disease

Treatments

Other: serum levels of angiogenin, bFGF, VEGF

Study type

Observational

Funder types

Other

Identifiers

NCT01720628
AFV-5813

Details and patient eligibility

About

Objectives: Behçet's disease (BD) is a systemic vasculitis. Since vascular endothelial dysfunction plays a prominent role in the pathogenesis of the disease, we considered angiogenic cytokines as an interesting target for investigation in BD. The aim of this study was to investigate the possible role of angiogenin, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of BD.

Design and Methods: Sixty five patients with BD and 21 healthy control subjects were included in the study. Serum angiogenin, bFGF and VEGF concentrations were determined by using in vitro enzyme immunoassay (ELISA) kits according to the manufacturer's instructions.

Enrollment

86 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age between 18-65
  • fulfilling the international diagnostic criteria for Behçet's disease

Exclusion criteria

  • to have another systemic disease

Trial design

86 participants in 1 patient group

Behçet's patients
Description:
Serum levels of angiogenin, bFGF, VEGF levels in Behçet's patients with ocular involvement group, without ocular involvement group and control group
Treatment:
Other: serum levels of angiogenin, bFGF, VEGF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems